Histogen Inc (HSTO)
0.351
0.00 (0.00%)
USD |
OTCM |
Apr 26, 11:25
Histogen Profit Margin (Quarterly): -77.02K% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -77.02K% |
| June 30, 2023 | -41.84K% |
| March 31, 2023 | -69.40K% |
| December 31, 2022 | -74.10K% |
| September 30, 2022 | -71.92K% |
| June 30, 2022 | -67.76K% |
| March 31, 2022 | -17.92% |
| December 31, 2021 | -62.70K% |
| September 30, 2021 | -649.9% |
| Date | Value |
|---|---|
| June 30, 2021 | -74.08K% |
| March 31, 2021 | -1.34K% |
| December 31, 2020 | -733.9% |
| September 30, 2020 | -656.4% |
| June 30, 2020 | -9.41K% |
| March 31, 2020 | -188.5% |
| December 31, 2019 | -148.0% |
| September 30, 2019 | -539.5% |
| June 30, 2019 | -305.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-77.02K%
Minimum
Sep 2023
-17.92%
Maximum
Mar 2022
-30.71K%
Average
-5.38K%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.1% |
| Return on Assets | -80.72% |
| Return on Invested Capital | -117.6% |
| Operating Margin (Quarterly) | -70.50K% |
| Return on Net Operating Assets | -296.9% |